Botulinum-Toxin A
✍ Scribed by Heinen, F. ;Mall, V. ;Wissel, J. ;Bernius, P. ;Stücker, R. ;Linder, M. ;Philipsen, A. ;Korinthenberg, R.
- Publisher
- Springer
- Year
- 1997
- Tongue
- German
- Weight
- 187 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0026-9298
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Botulinum toxin type A (btx A) injections are the most effective treatment for most patients with focal dystonia. Some patients who improve after btx A injections and later lose response have serologic evidence of antibodies to btx A with the mouse neutralization assay (seropositive pat
## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight